Epinex Diagnostics, Inc. could raise up to $1.7 million in private equity offering

In an SEC filing, Epinex Diagnostics, Inc. disclosed it has raised $318,000 from outside investors, and could raise up to $1.7 million in a private equity offering. Epinex is developing two handheld devices to test glycated albumin, one for us in the home and one for the doctor's office. If successful, Epinex could provide on-the-spot testing for glycated albumin, a test that's currently done through a laboratory.

Testing glycated albumin levels allows physicians and patients the ability to monitor intermediate glucose control that takes place between daily monitoring and regular A1c tests. Epinex's test, the G1A Test, "...shows how well the patients have controlled their level of glycation over the previous month."

Read the full story

Sign up for our newsletter
  • Get diabetes supplies
    delivered to your door.
  • Find companies that offer free
    delivery of the brands you want.

  • Diabetes supplies
     CPAP mask and tubing
  • How would you describe yourself?

  • Do you have Medicare as your primary insurance?
  • Yes No

Popular Latest News Articles

Add a comment
Google Plus
(required) *
(required,will not be displayed) *
Can't read this?
Get two new words
Listen to the words